Jacobs Levy Equity Management
CLX icon

Jacobs Levy Equity Management’s Clorox CLX Stock Holding History

Jacobs Levy Equity Management’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.5M Buy
518,266
+141,215
+37% +$13.6M 0.18% 129
2026
Q1 		$39.1M Buy
377,051
+15,571
+4% +$1.77M 0.16% 145
2025
Q4 		$36.4M Buy
361,480
+138,820
+62% +$15.1M 0.14% 138
2025
Q3 		$27.5M Sell
222,660
-11,799
-5% -$1.46M 0.11% 170
2025
Q2 		$28.2M Buy
234,459
+35,721
+18% +$4.77M 0.11% 171
2025
Q1 		$29.3M Buy
198,738
+180,238
+974% +$27.5M 0.12% 182
2024
Q4 		$3M Buy
+18,500
New +$3.03M 0.01% 525
2023
Q4 		– Sell
-14,373
Closed -$1.88M – 994
2023
Q3 		$1.88M Buy
+14,373
New +$2.18M 0.01% 567
2023
Q1 		– Sell
-157,785
Closed -$22.1M – 977
2022
Q4 		$22.1M Sell
157,785
-19,803
-11% -$2.81M 0.15% 175
2022
Q3 		$22.8M Buy
177,588
+114,331
+181% +$16.5M 0.18% 148
2022
Q2 		$8.92M Buy
+63,257
New +$9.04M 0.07% 299
2021
Q1 		– Sell
-1,629
Closed -$329K – 1028
2020
Q4 		$329K Buy
+1,629
New +$337K ﹤0.01% 908
2017
Q4 		– Sell
-2,390
Closed -$315K – 995
2017
Q3 		$315K Buy
2,390
+170
+8% +$22.8K 0.01% 781
2017
Q2 		$296K Buy
2,220
+40
+2% +$5.4K 0.01% 772
2017
Q1 		$294K Buy
+2,180
New +$282K 0.01% 726
2016
Q4 		– Sell
-2,879
Closed -$360K – 973
2016
Q3 		$360K Sell
2,879
-630
-18% -$82.5K 0.01% 771
2016
Q2 		$486K Sell
3,509
-39,310
-92% -$5.1M 0.01% 764
2016
Q1 		$5.4M Buy
42,819
+34,629
+423% +$4.4M 0.11% 218
2015
Q4 		$1.04M Buy
+8,190
New +$1.02M 0.02% 441

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jacobs Levy Equity Management's CLX Position: Q2 2026 in Review

Jacobs Levy Equity Management increased its Clorox (CLX) stake by 37% in Q2 2026, buying an estimated $13.6M and bringing the position to 518,266 shares worth $49.5M. The position accounts for 0.18% of the portfolio, ranked #129.

Jacobs Levy Equity Management first reported a position in CLX in Q4 2015 and has held it in 19 quarters since. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Jacobs Levy Equity Management held 518,266 shares of Clorox worth $49.5M as of Q2 2026.
  • Jacobs Levy Equity Management bought 141,215 Clorox shares in Q2 2026, an estimated $13.6M.
  • Clorox made up 0.18% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #129 holding.
  • Jacobs Levy Equity Management first reported a position in Clorox in Q4 2015 and has held it in 19 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.